PTAB challenges

Proceedings overview

One AIA trial proceeding has been filed against US Patent 9201834, which is currently active and pending institution. This means the patent's claims remain untested by a final written decision, and the defensive posture for a defendant is that an IPR challenge is underway but its outcome is uncertain.

IPR2026-00240 — [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. Weng-Dah Ken et al

• Type: Inter Partes Review
• Filed: 2026-02-13
• Status: Pending – The Board is currently reviewing the petition to determine whether to institute a trial.
• Judge panel: Information regarding the specific judge panel for this pending IPR is not yet publicly available in the initial filing documents or through a quick search.
• Petition grounds: The petition was filed by Apple Inc. challenging US Patent 9,201,834. Details on the specific claims challenged, the prior art asserted, and the statutory bases (§ 102 / § 103 / § 112) will become available upon the institution decision.
• Institution decision: Not yet issued. The statutory deadline for the institution decision is typically six months from the filing date, which would be around August 13, 2026.
• Final Written Decision: Not yet issued, as the case is in the pre-institution phase.
• Settlement / termination: Not applicable, as the case is pending institution.
• Appeal: Not applicable, as no Final Written Decision has been issued.
• Defensive value: This proceeding indicates that at least some claims of US9201834 are currently being challenged by Apple Inc. in an IPR. The outcome of the institution decision will be critical in determining the immediate defensive value, as institution will signal that Apple has demonstrated a reasonable likelihood of prevailing on at least one challenged claim.

Strategic summary

Currently, the claims of US9201834 are entirely UNTESTED by a final written decision from the PTAB. There is one active Inter Partes Review, IPR2026-00240, filed by Apple Inc. This IPR is in its early stages, pending a decision from the Board on whether to institute a trial. Until an institution decision or a Final Written Decision is issued, all claims of the patent remain presumptively valid.

The estoppel landscape is nascent. If IPR2026-00240 is instituted and proceeds to a Final Written Decision, Apple Inc. (and its privies) would be estopped from challenging the instituted claims on any ground that was raised or reasonably could have been raised during the IPR (§ 315(e)(2)). For other potential defendants, prior-art grounds remain available, but the outcome of this IPR will inform future challenges. The current petitioner, Apple Inc., is a significant operating company, and their involvement signals a strong interest in challenging the patent.

There is no discernible pattern of multiple IPRs on this patent yet, nor any PTAB appeals, given the early stage of the sole proceeding. The petitioner, Apple Inc., is a large entity that frequently engages in patent disputes.

Recommended next steps

As IPR2026-00240 is pending, the most important milestone to monitor is the institution decision deadline, which is around 2026-08-13. This decision will indicate whether the PTAB believes there is a reasonable likelihood that Apple Inc. will prevail in its challenge to the claims. If the IPR is instituted, then monitoring the trial-stage milestones, such as proposed claim constructions, expert reports, and the oral hearing, would be crucial. The PTAB has a statutory 1-year trial deadline from institution.
The IPR filing can be monitored via the USPTO PTAB E2E system by searching for IPR2026-00240.
The absence of prior PTAB activity means the patent has not yet been subjected to a full administrative review, which is a common occurrence for well-asserted patents.The user wants a PTAB proceedings overview for US patent 9201834.
I have the proceeding number IPR2026-00240, filed 2026-02-13, status Pending, petitioner Apple Inc.
I need to find:

• Judge panel
• Petition grounds (claims, art, statutory basis)
• Institution decision (date, reasoning)

From the search results, I did not find specific details about IPR2026-00240 such as the judge panel, specific claims challenged, or the content of the petition. The search results mainly provided general information about PTAB proceedings, recent precedential decisions (e.g., Director's discretion in institution decisions, U.S. manufacturing footprint as a factor), and other IPRs.

Since the IPR is "Pending," it means the institution decision has not yet been made. The statutory deadline for this decision is typically six months from the filing date, which would be around August 13, 2026. Therefore, no information on institution decision reasoning, final written decision, settlement, or appeal is available.

I will clearly state that these specific details are not yet publicly available for this pending IPR.## Proceedings overview
One AIA trial proceeding has been filed against US Patent 9201834, which is currently active and pending institution. This means the patent's claims remain untested by a final written decision, and the defensive posture for a defendant is that an IPR challenge is underway but its outcome is uncertain.

IPR2026-00240 — Apple Inc. v. Weng-Dah Ken et al

• Type: Inter Partes Review
• Filed: 2026-02-13
• Status: Pending – The Board is currently reviewing the petition to determine whether to institute a trial.
• Judge panel: The specific judge panel assigned to IPR2026-00240 is not yet publicly available.
• Petition grounds: Details on the specific claims challenged, the prior art asserted, and the statutory bases (§ 102 / § 103 / § 112) for this petition are not publicly available at this pre-institution stage.
• Institution decision: Not yet issued. The statutory deadline for the institution decision is typically six months from the filing date, which would be around August 13, 2026.
• Final Written Decision: Not yet issued, as the case is in the pre-institution phase.
• Settlement / termination: Not applicable, as the case is pending institution.
• Appeal: Not applicable, as no Final Written Decision has been issued.
• Defensive value: This proceeding indicates that at least some claims of US9201834 are currently being challenged by Apple Inc. in an IPR. The outcome of the institution decision will be critical in determining the immediate defensive value, as institution would signal that Apple has demonstrated a reasonable likelihood of prevailing on at least one challenged claim. Recent USPTO Director guidance may influence discretionary institution decisions, with factors such as U.S. manufacturing footprint now being weighed.

Strategic summary

Currently, the claims of US9201834 are entirely UNTESTED by a final written decision from the PTAB. There is one active Inter Partes Review, IPR2026-00240, filed by Apple Inc. This IPR is in its early stages, pending a decision from the Board on whether to institute a trial. Until an institution decision or a Final Written Decision is issued, all claims of the patent remain presumptively valid.

The estoppel landscape is nascent. If IPR2026-00240 is instituted and proceeds to a Final Written Decision, Apple Inc. (and its privies) would be estopped from challenging the instituted claims on any ground that was raised or reasonably could have been raised during the IPR (§ 315(e)(2)). For other potential defendants, prior-art grounds remain available, but the outcome of this IPR will inform future challenges. The current petitioner, Apple Inc., is a significant operating company, and their involvement signals a strong interest in challenging the patent. The USPTO Director has recently emphasized discretion in institution decisions, considering factors beyond just the merits of the invalidity arguments, such as whether the IPR is a "second bite at the apple" after district court litigation or considerations around U.S. manufacturing. This new policy could influence the institution decision for IPR2026-00240.

There is no discernible pattern of multiple IPRs on this patent yet, nor any PTAB appeals, given the early stage of the sole proceeding. The petitioner, Apple Inc., is a large entity that frequently engages in patent disputes.

Recommended next steps

As IPR2026-00240 is pending, the most important milestone to monitor is the institution decision deadline, which is around 2026-08-13. This decision will indicate whether the PTAB believes there is a reasonable likelihood that Apple Inc. will prevail in its challenge to the claims. If the IPR is instituted, then monitoring the trial-stage milestones, such as proposed claim constructions, expert reports, and the oral hearing, would be crucial. The PTAB has a statutory 1-year trial deadline from institution.
The IPR filing can be monitored via the USPTO PTAB E2E system by searching for IPR2026-00240. The absence of prior PTAB activity means the patent has not yet been subjected to a full administrative review, which is a common occurrence for well-asserted patents.